Primary immunodeficiencies suggest redundancy within the human immune system

Science Immunology

Volumn 1, Issue 6, 2016, Pages

  Fischer, Alain ^a,b,c,d   Rausell, Antonio ^a  

^a University of Sorbonne Paris la Cité   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM   (France)

^d Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85021030302     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aah5861     Document Type: Article

References (77)

1. M. A. Harris, J. Clark, A. Ireland, J. Lomax, M. Ashburner, R. Foulger, K. Eilbeck, S. Lewis, B. Marshall, C. Mungall, J. Richter, G. M. Rubin, J. A. Blake, C. Bult, M. Dolan, H. Drabkin, J. T. Eppig, D. P. Hill, L. Ni, M. Ringwald, R. Balakrishnan, J. M. Cherry, K. R. Christie, M. C. Costanzo, S. S. Dwight, S. Engel, D. G. Fisk, J. E. Hirschman, E. L. Hong, R. S. Nash, A. Sethuraman, C. L. Theesfeld, D. Botstein, K. Dolinski, B. Feierbach, T. Berardini, S. Mundodi, S. Y. Rhee, R. Apweiler, D. Barrell, E. Camon, E. Dimmer, V. Lee, R. Chisholm, P. Gaudet, W. Kibbe, R. Kishore, E. M. Schwarz, P. Sternberg, M. Gwinn, L. Hannick, J. Wortman, M. Berriman, V. Wood, N. de la Cruz, P. Tonellato, P. Jaiswal, T. Seigfried, R. White; Gene Ontology Consortium, The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32, D258–D261 (2004).
2. M. Deschamps, G. Laval, M. Fagny, Y. Itan, L. Abel, J.-L. Casanova, E. Patin, L. Quintana-Murci, Genomic signatures of selective pressures and introgression from archaic hominins at human innate immunity genes. Am. J. Hum. Genet. 98, 5–21 (2016).
3. A. Rausell, P. J. McLaren, A. Telenti, HIV and innate immunity—A genomics perspective. F1000Prime Rep. 5, 29 (2013).
4. C. A. Janeway Jr., Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (Pt 1), 1–13 (1989).
5. A. Rivera, M. C. Siracusa, G. S. Yap, W. C. Gause, Innate cell communication kick-starts pathogen-specific immunity. Nat. Immunol. 17, 356–363 (2016).
6. F. Leulier, B. Lemaitre, Toll-like receptors—Taking an evolutionary approach. Nat. Rev. Genet. 9, 165–178 (2008).
7. T. Kawai, S. Akira, The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 11, 373–384 (2010).
8. C. T. Ng, J. L. Mendoza, K. C. Garcia, M. B. A. Oldstone, Alpha and beta type 1 interferon signaling: Passage for diverse biologic outcomes. Cell 164, 349–352 (2016).
9. J. W. Schoggins, S. J. Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, C. M. Rice, A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011).
10. G. W. Litman, J. P. Rast, S. D. Fugmann, The origins of vertebrate adaptive immunity. Nat. Rev. Immunol. 10, 543–553 (2010).
11. G. Gasteiger, A. Y. Rudensky, Interactions between innate and adaptive lymphocytes. Nat. Rev. Immunol. 14, 631–639 (2014).
12. I. Mathieson, I. Lazaridis, N. Rohland, S. Mallick, N. Patterson, S. Alpaslan Roodenberg, E. Harney, K. Stewardson, D. Fernandes, M. Novak, K. Sirak, C. Gamba, E. R. Jones, B. Llamas, S. Dryomov, J. Pickrell, J. Luís Arsuaga, J. M. Bermúdez de Castro, E. Carbonell, F. Gerritsen, A. Khokhlov, P. Kuznetsov, M. Lozano, H. Meller, O. Mochalov, V. Moiseyev, M. A. Rojo Guerra, J. Roodenberg, J. Maria Vergès, J. Krause, A. Cooper, K. W. Alt, D. Brown, D. Anthony, C. Lalueza-Fox, W. Haak, R. Pinhasi, D. Reich, Genome-wide patterns of selection in 230 ancient Eurasians. Nature 528, 499–503 (2015).
13. E. K. Karlsson, D. P. Kwiatkowski, P. C. Sabeti, Natural selection and infectious disease in human populations. Nat. Rev. Genet. 15, 379–393 (2014).
14. A. Rausell, A. Telenti, Genomics of host-pathogen interactions. Curr. Opin. Immunol. 30, 32–38 (2014).
15. L. Quintana-Murci, A. G. Clark, Population genetic tools for dissecting innate immunity in humans. Nat. Rev. Immunol. 13, 280–293 (2013).
16. M. Sironi, R. Cagliani, D. Forni, M. Clerici, Evolutionary insights into host–pathogen interactions from mammalian sequence data. Nat. Rev. Genet. 16, 224–236 (2015).
17. A. Rausell, P. Mohammadi, P. J. McLaren, I. Bartha, I. Xenarios, J. Fellay, A. Telenti, Analysis of stop-gain and frameshift variants in human innate immunity genes. PLOS Comput. Biol. 10, e1003757 (2014).
18. F. M. Key, J. C. Teixeira, C. de Filippo, A. M. Andrés, Advantageous diversity maintained by balancing selection in humans. Curr. Opin. Genet. Dev. 29, 45–51 (2014).
19. J.-L. Casanova, L. Abel, L. Quintana-Murci, Human TLRs and IL-1Rs in host defense: Natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447–491 (2011).
20. P. J. Norman, L. Abi-Rached, K. Gendzekhadze, D. Korbel, M. Gleimer, D. Rowley, D. Bruno, C. V. F. Carrington, D. Chandanayingyong, Y.-H. Chang, C. Crespí, G. Saruhan-Direskeneli, P. A. Fraser, K. Hameed, G. Kamkamidze, K. A. Koram, Z. Layrisse, N. Matamoros, J. Milà, M. H. Park, R. M. Pitchappan, D. D. Ramdath, M.-Y. Shiau, H. A. F. Stephens, S. Struik, D. H. Verity, R. W. Vaughan, D. Tyan, R. W. Davis, E. M. Riley, M. Ronaghi, P. Parham, Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 39, 1092–1099 (2007).
21. M. Dannemann, A. M. Andrés, J. Kelso, Introgression of Neandertal- and Denisovan-like haplotypes contributes to adaptive variation in human toll-like receptors. Am. J. Hum. Genet. 98, 22–33 (2016).
22. A. L. Hughes, M. Yeager, Natural selection at major histocompatibility complex loci of vertebrates. Annu. Rev. Genet. 32, 415–435 (1998).
23. F. Prugnolle, A. Manica, M. Charpentier, J. F. Guégan, V. Guernier, F. Balloux, Pathogen-driven selection and worldwide HLA class I diversity. Curr. Biol. 15, 1022–1027 (2005).
24. S. Nish, R. Medzhitov, Host defense pathways: Role of redundancy and compensation in infectious disease phenotypes. Immunity 34, 629–636 (2011).
25. L. K. Beura, S. E. Hamilton, K. Bi, J. M. Schenkel, O. A. Odumade, K. A. Casey, E. A. Thompson, K. A. Fraser, P. C. Rosato, A. Filali-Mouhim, R. P. Sekaly, M. K. Jenkins, V. Vezys, W. Nicholas Haining, S. C. Jameson, D. Masopust, Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512–516 (2016).
26. C. Picard, W. Al-Herz, A. Bousfiha, J.-L. Casanova, T. Chatila, M. E. Conley, C. Cunningham-Rundles, A. Etzioni, S. M. Holland, C. Klein, S. Nonoyama, H. D. Ochs, E. Oksenhendler, J. M. Puck, K. E. Sullivan, M. L. K. Tang, J. L. Franco, H. B. Gaspar, Primary Immunodeficiency Diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 35, 696–726 (2015).
27. CEREDIH: The French PID Study Group, The French national registry of primary immunodeficiency disease. Clin. Immunol. 135, 264–272 (2010).
28. A. A. de Jesus, S. W. Canna, Y. Liu, R. Goldbach-Mansky, Molecular mechanisms in genetically defined autoinflammatory diseases: Disorders of amplified danger signaling. Annu. Rev. Immunol. 33, 823–874 (2015).
29. Q. Zhou, H. Wang, D. M. Schwartz, M. Stoffels, Y. H. Park, Y. Zhang, D. Yang, E. Demirkaya, M. Takeuchi, W. L. Tsai, J. J. Lyons, X. Yu, C. Ouyang, C. Chen, D. T. Chin, K. Zaal, S. C. Chandrasekharappa, E. P. Hanson, Z. Yu, J. C. Mullikin, S. A. Hasni, I. E. Wertz, A. K. Ombrello, D. L. Stone, P. Hoffmann, A. Jones, B. K. Barham, H. L. Leavis, A. van Royen-Kerkof, C. Sibley, E. D. Batu, A. Gül, R. M. Siegel, M. Boehm, J. D. Milner, S. Ozen, M. Gadina, J. Chae, R. M. Laxer, D. L. Kastner, I. Aksentijevich, Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat. Genet. 48, 67–73 (2016).
30. L. D. Notarangelo, M.-S. Kim, J. E. Walter, Y. N. Lee, Human RAG mutations: Biochemistry and clinical implications. Nat. Rev. Immunol. 16, 234–246 (2016).
31. C. Picard, H. von Bernuth, P. Ghandil, M. Chrabieh, O. Levy, P. D. Arkwright, D. McDonald, R. S. Geha, H. Takada, J. C. Krause, C. B. Creech, C. L. Ku, S. Ehl, L. Maródi, S. Al-Muhsen, S. Al-Hajjar, A. Al-Ghonaium, N. K. Day-Good, S. M. Holland, J. I. Gallin, H. Chapel, D. P. Speert, C. Rodriguez-Gallego, E. Colino, B. Z. Garty, C. Roifman, T. Hara, H. Yoshikawa, S. Nonoyama, J. Domachowske, A. C. Issekutz, M. Tang, J. Smart, S. E. Zitnik, C. Hoarau, D. S. Kumararatne, A. J. Thrasher, E. G. Davies, C. Bethune, N. Sirvent, D. de Ricaud, Y. Camcioglu, J. Vasconcelos, M. Guedes, A. B. Vitor, C. Rodrigo, F. Almazán, M. Méndez, J. I. Aróstegui, L. Alsina, C. Fortuny, J. Reichenbach, J. W. Verbsky, X. Bossuyt, R. Doffinger, L. Abel, A. Puel, J. L. Casanova, Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89, 403–425 (2010).
32. F. Hauck, C. Klein, Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr. Opin. Allergy Clin. Immunol. 13, 596–606 (2013).
33. E. van de Vijver, T. K. van den Berg, T. W. Kuijpers, Leukocyte adhesion deficiencies. Hematol. Oncol. Clin. North Am. 27, 101–116 (2013).
34. S. M. Holland, Chronic granulomatous disease. Hematol. Oncol. Clin. North Am. 27, 89–99 (2013).
35. A. Fischer, L. D. Notarangelo, B. Neven, M. Cavazzana, J. M. Puck, Severe combined immunodeficiencies and related disorders. Nat. Rev. Dis. Primers 1, 15061 (2015).
36. L. D. Notarangelo, Functional T cell immunodeficiencies (with T cells present). Annu. Rev. Immunol. 31, 195–225 (2013).
37. A. Durandy, S. Kracker, A. Fischer, Primary antibody deficiencies. Nat. Rev. Immunol. 13, 519–533 (2013).
38. Y. J. Crow, N. Manel, Aicardi–Goutières syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429–440 (2015).
39. A. Puel, S. Cypowyj, L. Maródi, L. Abel, C. Picard, J. L. Casanova, Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 12, 616–622 (2012).
40. J.-L. Casanova, M. E. Conley, S. J. Seligman, L. Abel, L. D. Notarangelo, Guidelines for genetic studies in single patients: Lessons from primary immunodeficiencies. J. Exp. Med. 211, 2137–2149 (2014).
41. I. Bartha, A. Rausell, P. J. McLaren, P. Mohammadi, M. Tardaguila, N. Chaturvedi, J. Fellay, A. Telenti, The characteristics of heterozygous protein truncating variants in the human genome. PLOS Comput. Biol. 11, e1004647 (2015).
42. M. Lek, K. Karczewski, E. Minikel, K. Samocha, E. Banks, T. Fennell, A. O’Donnell-Luria, J. Ware, A. Hill, B. Cummings, T. Tukiainen, D. Birnbaum, J. Kosmicki, L. Duncan, K. Estrada, F. Zhao, J. Zou, E. Pierce-Hoffman, J. Berghout, D. Cooper, N. Deflaux, M. DePristo, R. Do, J. Flannick, M. Fromer, L. Gauthier, J. Goldstein, N. Gupta, D. Howrigan, A. Kiezun, M. Kurki, A. Levy Moonshine, P. Natarajan, L. Orozco, G. Peloso, R. Poplin, M. Rivas, V. Ruano-Rubio, S. Rose, D. Ruderfer, K. Shakir, P. Stenson, C. Stevens, B. Thomas, G. Tiao, M. Tusie-Luna, B. Weisburd, H.-H. Won, D. Yu, D. Altshuler, D. Ardissino, M. Boehnke, J. Danesh, S. Donnelly, E. Roberto, J. Florez, S. Gabriel, G. Getz, S. Glatt, C. Hultman, S. Kathiresan, M. Laakso, S. McCarroll, M. McCarthy, D. McGovern, R. McPherson, B. Neale, A. Palotie, S. Purcell, D. Saleheen, J. Scharf, P. Sklar, P. Sullivan, J. Tuomilehto, M. Tsuang, H. Watkins, J. Wilson, M. Daly, D. MacArthur; Exome Aggregation Consortium, Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
43. L. Hammarstrom, Genetic Approach to Common Variable Immunodeficiency and IgA Deficiency in Primary Immunodeficiency Diseases, H. D. Ochs, C. I. E. Smith, J. M. Puck, Eds. (Oxford Univ. Press, 2014), chap. 28, pp. 356–365.
44. M. W. Turner, The role of mannose-binding lectin in health and disease. Mol. Immunol. 40, 423–429 (2003).
45. S. Thiel, P. D. Frederiksen, J. C. Jensenius, Clinical manifestations of mannan-binding lectin deficiency. Mol. Immunol. 43, 86–96 (2006).
46. B. Ferwerda, G. Ferwerda, T. S. Plantinga, J. A. Willment, A. B. van Spriel, H. Venselaar, C. C. Elbers, M. D. Johnson, A. Cambi, C. Huysamen, L. Jacobs, T. Jansen, K. Verheijen, L. Masthoff, S. A. Morré, G. Vriend, D. L. Williams, J. R. Perfect, L. A. Joosten, C. Wijmenga, J. W. van der Meer, G. J. Adema, B. J. Kullberg, G. D. Brown, M. G. Netea, Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361, 1760–1767 (2009).
47. L. Y. A. Chai, M. G. J. de Boer, W. J. F. M. van der Velden, T. S. Plantinga, A. B. van Spriel, C. Jacobs, C. J. M. Halkes, A. G. Vonk, N. M. Blijlevens, J. T. van Dissel, P. J. Donnelly, B.-J. Kullberg, J. Maertens, M. G. Netea, The Y238X stop codon polymorphism in the human b-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J. Infect. Dis. 203, 736–743 (2011).
48. S. Hambleton, S. Salem, J. Bustamante, V. Bigley, S. Boisson-Dupuis, J. Azevedo, A. Fortin, M. Haniffa, L. Ceron-Gutierrez, C. M. Bacon, G. Menon, C. Trouillet, D. McDonald, P. Carey, F. Ginhoux, L. Alsina, T. J. Zumwalt, X. F. Kong, D. Kumararatne, K. Butler, M. Hubeau, J. Feinberg, S. Al-Muhsen, A. Cant, L. Abel, D. Chaussabel, R. Doffinger, E. Talesnik, A. Grumach, A. Duarte, K. Abarca, D. Moraes-Vasconcelos, D. Burk, A. Berghuis, F. Geissmann, M. Collin, J. L. Casanova, P. Gros, IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127–138 (2011).
49. D. Artis, H. Spits, The biology of innate lymphoid cells. Nature 517, 293–301 (2015).
50. S. D. Scoville, B. L. Mundy-Bosse, M. H. Zhang, L. Chen, X. Zhang, K. A. Keller, T. Hughes, L. Chen, S. Cheng, S. M. Bergin, H. C. Mao, S. McClory, J. Yu, W. E. Carson III, M. A. Caligiuri, A. G. Freud, A progenitor cell expressing transcription factor RORgt generates all human innate lymphoid cell subsets. Immunity 44, 1140–1150 (2016).
51. H.-Y. Shih, G. Sciumè, Y. Mikami, L. Guo, H.-W. Sun, S. R. Brooks, J. F. Urban Jr., F. P. Davis, Y. Kanno, J. J. O’Shea, Developmental acquisition of regulomes underlies innate lymphoid cell functionality. Cell 165, 1120–1133 (2016).
52. O. I. Koues, P. L. Collins, M. Cella, M. L. Robinette, S. I. Porter, S. C. Pyfrom, J. E. Payton, M. Colonna, E. M. Oltz, Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells. Cell 165, 1134–1146 (2016).
53. W. J. Leonard, The molecular basis of X-linked severe combined immunodeficiency: Defective cytokine receptor signaling. Annu. Rev. Med. 47, 229–239 (1996).
54. T. Vely, V. Barlogis, B. Vallentin, B. Neven, C. Piperoglou, M. Ebbo, T. Perchet, M. Petit, N. Yessaad, F. Touzot, J. Bruneau, N. Mahlaoui, N. Zucchini, C. Farnarier, G. Michel, D. Moshous, S. Blanche, A. Dujardin, H. Spits, J. H. Distler, A. Ramming, C. Picard, R. Golub, A. Fischer, E. Vivier, Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17, 1291–1299 (2016).
55. R. H. Buckley, S. E. Schiff, R. I. Schiff, L. Markert, L. W. Williams, J. L. Roberts, L. A. Myers, F. E. Ward, Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N. Engl. J. Med. 340, 508–516 (1999).
56. A. Fischer, F. Le Deist, S. Hacein-Bey-Abina, I. André-Schmutz, G. De Saint Basile, J.-P. De Villartay, M. Cavazzana-Calvo, Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203, 98–109 (2005).
57. A. Iwasaki, R. Medzhitov, Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343–353 (2015).
58. G. de Saint Basile, G. Ménasché, A. Fischer, Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat. Rev. Immunol. 10, 568–579 (2010).
59. A. L. Graham, J. E. Allen, A. F. Read, Evolutionary causes and consequences of immunopathology. Annu. Rev. Ecol. Evol. Syst. 36, 373–397 (2005).
60. M. Pizza, R. Rappuoli, Neisseria meningitidis: Pathogenesis and immunity. Curr. Opin. Microbiol. 23, 68–72 (2015).
61. + T lymphocytes. Immunity 42, 929–941 (2015).
62. H. Wardemann, S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, M. C. Nussenzweig, Predominant autoantibody production by early human B cell precursors. Science 301, 1374–1377 (2003).
63. M. H. Cheng, M. S. Anderson, Monogenic autoimmunity. Annu. Rev. Immunol. 30, 393–427 (2012).
64. A. Fischer, Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends Mol. Med. 21, 408–416 (2015).
65. I. Aksentijevich, S. L. Masters, P. J. Ferguson, P. Dancey, J. Frenkel, A. van Royen-Kerkhoff, R. Laxer, U. Tedgård, E. W. Cowen, T.-H. Pham, M. Booty, J. D. Estes, N. G. Sandler, N. Plass, D. L. Stone, M. L. Turner, S. Hill, J. A. Butman, R. Schneider, P. Babyn, H. I. El-Shanti, E. Pope, K. Barron, X. Bing, A. Laurence, C.-C. R. Lee, D. Chapelle, G. I. Clarke, K. Ohson, M. Nicholson, M. Gadina, B. Yang, B. D. Korman, P. K. Gregersen, P. M. van Hagen, A. E. Hak, M. Huizing, P. Rahman, D. C. Douek, E. F. Remmers, D. L. Kastner, R. Goldbach-Mansky, An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist. N. Engl. J. Med. 360, 2426–2437 (2009).
66. G. I. Rice, P. R Kasher, G. M. A. Forte, N. M Mannion, S. M. Greenwood, M. Szynkiewicz, J. E. Dickerson, S. S. Bhaskar, M. Zampini, T. A. Briggs, E. M. Jenkinson, C. A. Bacino, R. Battini, E. Bertini, P. A. Brogan, L. A. Brueton, M. Carpanelli, C. De Laet, P. de Lonlay, M. del Toro, I. Desguerre, E. Fazzi, À. Garcia-Cazorla, A. Heiberg, M. Kawaguchi, R. Kumar, J.-P. S.-M. Lin, C. M. Lourenco, A. M. Male, W. Marques Jr., C. Mignot, I. Olivieri, S. Orcesi, P. Prabhakar, M. Rasmussen, R. A Robinson, F. Rozenberg, J. L. Schmidt, K. Steindl, T. Y. Tan, W. G. van der Merwe, A. Vanderver, G. Vassallo, E. L. Wakeling, E. Wassmer, E. Whittaker, J. H. Livingston, P. Lebon, T. Suzuki, P. J. McLaughlin, L. P. Keegan, M. A. O'Connell, S. C. Lovell, Y. J. Crow, Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat. Genet. 44, 1243–1248 (2012).
67. R. Medzhitov, D. S. Schneider, M. P. Soares, Disease tolerance as a defense strategy. Science 335, 936–941 (2012).
68. M. P. Soares, “Nuts and bolts” of disease tolerance. Immunity 41, 176–178 (2014).
69. D. M. da Fonseca, T. W. Hand, S.-J. Han, M. Y. Gerner, A. G. Zaretsky, A. L. Byrd, O. J. Harrison, A. M. Ortiz, M. Quinones, G. Trinchieri, J. M. Brenchley, I. E. Brodsky, R. N. Germain, G. J. Randolph, Y. Belkaid, Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 163, 354–366 (2015).
70. F. G. Lafaille, I. M. Pessach, S.-Y. Zhang, M. J. Ciancanelli, M. Herman, A. Abhyankar, S.-W. Ying, S. Keros, P. A. Goldstein, G. Mostoslavsky, J. Ordovas-Montanes, E. Jouanguy, S. Plancoulaine, E. Tu, Y. Elkabetz, S. Al-Muhsen, M. Tardieu, T. M. Schlaeger, G. Q. Daley, L. Abel, J.-L. Casanova, L. Studer, L. D. Notarangelo, Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491, 769–773 (2012).
71. M. N. Lee, C. Ye, A.-C. Villani, T. Raj, W. Li, T. M. Eisenhaure, S. H. Imboywa, P. I. Chipendo, F. A. Ran, K. Slowikowski, L. D. Ward, K. Raddassi, C. McCabe, M. H. Lee, I. Y. Frohlich, D. A. Hafler, M. Kellis, S. Raychaudhuri, F. Zhang, B. E. Stranger, C. O. Benoist, P. L. De Jager, A. Regev, N. Hacohen, Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 343, 1246980 (2014).
72. B. P. Fairfax, P. Humburg, S. Makino, V. Naranbhai, D. Wong, E. Lau, L. Jostins, K. Plant, R. Andrews, C. McGee, J. C. Knight, Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
73. P. Brodin, V. Jojic, T. Gao, S. Bhattacharya, C. J. Lopez Angel, D. Furman, S. Shen-Orr, C. L. Dekker, G. E. Swan, A. J. Butte, H. T. Maecker, M. M. Davis, Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47 (2015).
74. E. J. Carr, J. Dooley, J. E. Garcia-Perez, V. Lagou, J. C. Lee, C. Wouters, I. Meyts, A. Goris, G. Boeckxstaens, M. A. Linterman, A. Liston, The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 17, 461–468 (2016).
75. R. Banchereau, S. Hong, B. Cantarel, N. Baldwin, J. Baisch, M. Edens, A.-M. Cepika, P. Acs, J. Turner, E. Anguiano, P. Vinod, S. Khan, G. Obermoser, D. Blankenship, E. Wakeland, L. Nassi, A. Gotte, M. Punaro, Y.-J. Liu, J. Banchereau, J. Rossello-Urgell, T. Wright, V. Pascual, Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551–565 (2016).
76. J. Bustamante, S. Boisson-Dupuis, L. Abel, J.-L. Casanova, Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-g immunity. Semin. Immunol. 26, 454–470 (2014).
77. M. Her, A. Kavanaugh, Alterations in immune function with biologic therapies for autoimmune disease. J. Allergy Clin. Immunol. 137, 19–27 (2016).